Proteomics in Small Cell Lung Cancer
NCT05623956 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2025-01-31
Summary
The aim of this study is to gather insight into tumor-derived circulating extracellular vesicles-proteins in patients with newly diagnosed small cell lung cancer.
Conditions
Sponsors & Collaborators
-
Aalborg University Hospital
lead OTHER
Principal Investigators
-
Weronika Szejniuk, MD, PhD · Aalborg University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Specimen Banking From Patients With Lung Cancer
NCT01585675 ·Status: RECRUITING
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 ·Status: UNKNOWN
-
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
NCT05636605 ·Status: RECRUITING
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
NCT01415739 ·Status: WITHDRAWN
-
Biomarker Discovery and Validation in Lung Cancer
NCT01147562 ·Status: UNKNOWN ·Phase: NA
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
NCT07026669 ·Status: RECRUITING
-
Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
NCT01830426 ·Status: COMPLETED
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients
NCT03236675 ·Status: UNKNOWN
-
Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
NCT05889247 ·Status: RECRUITING ·Phase: NA
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
Tumor Molecular Profiling in Early Phase Clinical Trials
NCT04510766 ·Status: RECRUITING
-
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864 ·Status: RECRUITING
-
Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer
NCT01192256 ·Status: COMPLETED
-
Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung Cancer
NCT03512847 ·Status: COMPLETED
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
NCT05587114 ·Status: RECRUITING
-
Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer
NCT06907160 ·Status: RECRUITING
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
NCT03244904 ·Status: UNKNOWN